1. Academic Validation
  2. Indoloquinoline alkaloid neocryptolepine derivative inhibits Botrytis cinerea by targeting thiamine thiazole synthase

Indoloquinoline alkaloid neocryptolepine derivative inhibits Botrytis cinerea by targeting thiamine thiazole synthase

  • Sci Adv. 2025 Mar 14;11(11):eadq5329. doi: 10.1126/sciadv.adq5329.
Wen-Bin Zhao 1 Jun-Xia An 1 Ya-Rui Jin 1 Chen-Xin Jing 1 Shao-Yong Zhang 2 Hong-Jie Liang 1 Tian-Li Dai 1 Xiong-Fei Luo 1 Bao-Qi Zhang 1 Zhi-Jun Zhang 1 Ying-Qian Liu 1 2
Affiliations

Affiliations

  • 1 School of Pharmacy, Lanzhou University, Lanzhou, Gansu 730000, China.
  • 2 Key Laboratory of Vector Biology and Pathogen Control of Zhejiang Province, College of Life Science, Huzhou University, Huzhou, Zhejiang 313000, China.
Abstract

The emergence and rapid spread of multidrug-resistant Botrytis cinerea strains pose a great challenge to the quality and safety of agricultural products and the efficient use of pesticides. Previously unidentified fungicides and targets are urgently needed to combat B. cinerea-associated infections as alternative therapeutic options. In this study, the promising compound Z24 demonstrated efficacy against all tested plant pathogenic fungi. Thiamine thiazole synthase (Bcthi4) was identified as a target protein of Z24 by drug affinity responsive target stability (DARTS), cellular thermal shift assay (CETSA), and surface plasmon resonance (SPR) assays. Molecular docking and enzyme activity experiments have demonstrated that Z24 can affect the function of Bcthi4. Last, mechanistic studies show that Z24 inhibits thiamine biosynthesis by binding to Bcthi4 and induces up-regulation of alternative splicing [alternative 5' splice site (A5SS)] of the Bcthi4 gene. In conclusion, by targeting Bcthi4, Z24 has the potential to be developed as a previously unidentified anti-B. cinerea candidate.

Figures
Products